94 related articles for article (PubMed ID: 12861124)
1. SEOM clinical guideline on unknown primary cancer (2017).
Losa F; Soler G; Casado A; Estival A; Fernández I; Giménez S; Longo F; Pazo-Cid R; Salgado J; Seguí MÁ
Clin Transl Oncol; 2018 Jan; 20(1):89-96. PubMed ID: 29230692
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of unknown primary (CUP): an update for histopathologists.
Beauchamp K; Moran B; O'Brien T; Brennan D; Crown J; Sheahan K; Cotter MB
Cancer Metastasis Rev; 2023 Dec; 42(4):1189-1200. PubMed ID: 37394540
[TBL] [Abstract][Full Text] [Related]
3. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.
Lorkowski SW; Dermawan JK; Rubin BP
Virchows Arch; 2024 Feb; 484(2):369-375. PubMed ID: 37999736
[TBL] [Abstract][Full Text] [Related]
4. New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges.
Ma W; Wu H; Chen Y; Xu H; Jiang J; Du B; Wan M; Ma X; Chen X; Lin L; Su X; Bao X; Shen Y; Xu N; Ruan J; Jiang H; Ding Y
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38343328
[TBL] [Abstract][Full Text] [Related]
5. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Fizazi K; Greco FA; Pavlidis N; Daugaard G; Oien K; Pentheroudakis G;
Ann Oncol; 2015 Sep; 26 Suppl 5():v133-8. PubMed ID: 26314775
[No Abstract] [Full Text] [Related]
6. [Cancer of unknown primary-The new ESMO guidelines].
Bochtler T; Pouyiourou M; Krämer A
Radiologie (Heidelb); 2023 May; 63(5):329-335. PubMed ID: 36930265
[TBL] [Abstract][Full Text] [Related]
7. [Whole genome sequencing to find the primary tumour in cancer of unknown primary origin].
van der Hoeven JJM; Monkhorst K; van de Wouw AJ; Roepman P
Ned Tijdschr Geneeskd; 2023 Sep; 167():. PubMed ID: 37823879
[TBL] [Abstract][Full Text] [Related]
8. Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
Moore EC; Blobe GC; DeVito NC; Hanks BA; Harrison MR; Hoimes CJ; Jia J; Morse MA; Jayaprakasan P; MacKelfresh A; Mulder H; Hockenberry AJ; Zander A; Stumpe MC; Michuda J; Beauchamp KA; Perakslis E; Taxter T; George DJ
Cancer Med; 2023 Oct; 12(19):19394-19405. PubMed ID: 37712677
[TBL] [Abstract][Full Text] [Related]
9. Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary.
Moon I; LoPiccolo J; Baca SC; Sholl LM; Kehl KL; Hassett MJ; Liu D; Schrag D; Gusev A
Nat Med; 2023 Aug; 29(8):2057-2067. PubMed ID: 37550415
[TBL] [Abstract][Full Text] [Related]
10. Tracing unknown tumor origins with a biological-pathway-based transformer model.
Xie J; Chen Y; Luo S; Yang W; Lin Y; Wang L; Ding X; Tong M; Yu R
Cell Rep Methods; 2024 Jun; 4(6):100797. PubMed ID: 38889685
[TBL] [Abstract][Full Text] [Related]
11. Occult primary cancer clinical practice guidelines.
Ettinger DS; Arnoletti JP; Gockerman JP; Handorf C; Havlin KA; Jacobs CD; Javle M; Kvols L; Lenzi R; Rashid A; Rhoades CA; Ridge JA; Saltz L; Shulman LN; Sondak VK; Thompson JA; Twardowski P; Zhen W;
J Natl Compr Canc Netw; 2005 Mar; 3(2):214-33. PubMed ID: 19817031
[No Abstract] [Full Text] [Related]
12. Cancer of unknown primary derived from regressed breast cancer.
Pouyiourou M; Mokry T; Feszler M; Teifke A; Kreft A; Krämer A
J Cancer Res Clin Oncol; 2024 May; 150(5):229. PubMed ID: 38703270
[No Abstract] [Full Text] [Related]
13. Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.
Li Y; Li F; Li X; Qu L; Han J
Medicine (Baltimore); 2020 Dec; 99(50):e23210. PubMed ID: 33327238
[TBL] [Abstract][Full Text] [Related]
14. Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer.
Kulkarni A; Pillai R; Ezekiel AM; Henner WD; Handorf CR
Diagn Pathol; 2012 Aug; 7():110. PubMed ID: 22909314
[TBL] [Abstract][Full Text] [Related]
15. 92-Gene molecular profiling in identification of cancer origin: a retrospective study in Chinese population and performance within different subgroups.
Wu F; Huang D; Wang L; Xu Q; Liu F; Ye X; Meng X; Du X
PLoS One; 2012; 7(6):e39320. PubMed ID: 22761762
[TBL] [Abstract][Full Text] [Related]
16. [The initial CUP situation and CUP syndrome: pathological diagnostics].
Moll R
Pathologe; 2009 Dec; 30 Suppl 2():161-7. PubMed ID: 19816686
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of metastatic potential.
Winnard PT; Pathak AP; Dhara S; Cho SY; Raman V; Pomper MG
J Nucl Med; 2008 Jun; 49 Suppl 2(Suppl 2):96S-112S. PubMed ID: 18523068
[TBL] [Abstract][Full Text] [Related]
18. Cancer from an unknown primary site.
Dowell JE
Am J Med Sci; 2003 Jul; 326(1):35-46. PubMed ID: 12861124
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
